Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of repeat oral dosing of CNV2197944 75 mg tid on the pain
experienced in diabetic peripheral neuropathy (DPN) as measured by changes in PI-NRS after
three weeks of treatment compared to the baseline period.